“…Recent work has showcased that out of the many unique lipid classes found in the TFLL, the wax esters (WEs) and O -acyl-ω-hydroxy fatty acids (OAHFAs) hold significant potential from the DED treatment perspective. In more detail, they display the characteristic biophysical profiles required to promote active spreading of lipids at the aqueous interface (tear film stabilizing action) and enhance the evaporation resistance of the formed film (moderation of evaporation rate). , In our most recent work, we identified a promising lipid composition comprising the WE behenyl oleate (BO) and OAHFA 20-oleoyloxy-eicosanoic acid (20:0/18:1-OAHFA, later referred to as 20-OAHFA) which spread efficiently at the aqueous interface to yield a lipid film with excellent evaporation-resistant properties at physiological ocular surface pressure (20–40 mN/m) and temperature (35 °C) . In more detail, the 20-OAHFA was tailored to maintain the functional characteristics of the average TFLL OAHFA ((21 Z )-29-oleoyloxynonacos-21-enoic acid used as a model, i.e., 29:1/18:1-OAHFA, later referred to as 29-OAHFA), that is, to capture its surface-active properties, phase transition behavior, and evaporation-resistant function in an economically more sensible form. , This would be more appealing from an industrial upscaling perspective as the length of the synthetic routes are considerably shorter than those required to reach the naturally occurring OAHFAs (2–3 steps for 20-OAHFA vs 9–10 steps for 29-OAHFA) .…”